Smart Inhalers Market Sets New Record, Predicted to Hit USD 1.1 Billion by 2030 at 25.1% CAGR : AMR

Smart inhalers are devices used for delivering several inhaled medications, such as anticholinergics, glucocorticoids, and beta antagonists for treating respiratory diseases. Smart inhalers contain sensors that are connected to inhaler devices, which allows maintaining the record of inhaler, increasing the adherence, and monitoring of the patient. The report provides a detailed analysis of the top investment pockets, top winning strategies, drivers & opportunities, market size & estimations, competitive landscape, and evolving market trends. The market study is a helpful source of information for the frontrunners, new entrants, investors, and shareholders in crafting strategies for the future and heightening their position in the market.

Allied Market Research published a report, titled, “Smart Inhalers Market by Product (Inhalers and Nebulizers), Indication (Asthma and COPD), and Distribution Channel (Hospital Pharmacies and Retail Pharmacies): Global Opportunity Analysis and Industry Forecast, 2021–2030″. According to the report, the global Smart Inhalers Market Size was Valued at USD 118 million in 2020 and is Projected to Garner USD 1.1 billion by 2030, registering a CAGR of 25.1% from 2021 to 2030.

𝐖𝐡𝐚𝐭 𝐚𝐫𝐞 𝐭𝐡𝐞 𝐝𝐫𝐢𝐯𝐢𝐧𝐠 𝐟𝐚𝐜𝐭𝐨𝐫𝐬 𝐟𝐨𝐫 𝐭𝐡𝐞 𝐬𝐦𝐚𝐫𝐭 𝐢𝐧𝐡𝐚𝐥𝐞𝐫𝐬 𝐦𝐚𝐫𝐤𝐞𝐭?

Increase in tobacco consumption among men as well as women in developed countries and higher risk of exposure to indoor air pollution are expected to increase the prevalence of respiratory disease equally among both men and women, which drive the growth of the global smart inhalers market. However, the risk of data leakage hinders the market growth. On the other hand, various collaborations, partnerships, and acquisitions between pharmaceutical companies and smart inhaler manufacturers present new opportunities in the coming years.

𝐆𝐞𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐃𝐅 𝐑𝐞𝐩𝐨𝐫𝐭 𝐰𝐢𝐭𝐡 𝐆𝐫𝐚𝐩𝐡𝐬 𝐚𝐧𝐝 𝐅𝐢𝐠𝐮𝐫𝐞𝐬 𝐇𝐞𝐫𝐞: https://www.alliedmarketresearch.com/request-sample/1715

Covid-19 Scenario

• The outbreak of the COVID-19 pandemic has had a positive impact on the growth of the global smart inhalers market.
• Hospital and clinical visits increased significantly, due to surge in the number of cases related to chronic respiratory diseases. This in turn, led to increasing demand for inhalers and nebulizers, thus augmenting the market growth.

𝐓𝐨𝐩 𝐒𝐦𝐚𝐫𝐭 𝐈𝐧𝐡𝐚𝐥𝐞𝐫 𝐌𝐚𝐧𝐮𝐟𝐚𝐜𝐭𝐮𝐫𝐞𝐫: –

• Adherium Limited
• Aptar Group Inc. (Cohero Health Inc.)
• AstraZeneca, Inc.
• Cognita Labs, LLC
• GlaxoSmithKline Plc
• Novartis AG
• OPKO Health Inc.
• Philip Morris International Inc. (Vectura Group Plc)
• Resmed Inc. (Propeller Health)
• Teva Pharmaceutical Industries Ltd.

𝐒𝐦𝐚𝐫𝐭 𝐈𝐧𝐡𝐚𝐥𝐞𝐫𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧 𝐜𝐚𝐧 𝐛𝐞 𝐝𝐨𝐧𝐞 𝐛𝐚𝐬𝐞𝐝 𝐨𝐧 𝐬𝐞𝐯𝐞𝐫𝐚𝐥 𝐟𝐚𝐜𝐭𝐨𝐫𝐬, 𝐢𝐧𝐜𝐥𝐮𝐝𝐢𝐧𝐠:.

Based on indication, the asthma segment held the highest market share in 2020, accounting for more than half of the global smart inhalers market, and is estimated to maintain its leadership status throughout the forecast period, owing to increasing cases of asthma patients. Moreover, the COPD segment is projected to manifest the highest CAGR of 25.4% from 2021 to 2030, owing to increasing cases of patients suffering from chronic obstructive pulmonary disease (COPD).

Based on distribution channel, the retail pharmacies segment accounted for the largest share in 2020, contributing to nearly three-fifths of the global smart inhalers market, and is projected to maintain its lead position during the forecast period. Moreover, the same segment is expected to portray the largest CAGR of 25.4% from 2021 to 2030, owing to ease of availability of wide range of inhalers in the retail pharmacies.

Based on region, North America held the highest market share in terms of revenue 2020, accounting for nearly two-fifths of the global smart inhalers market. This is owing to rise in respiratory diseases, rapid adoption of advanced technologies and presence of key players across North America. Moreover, the Asia-Pacific region is expected to witness the fastest CAGR of 27.4% during the forecast period, owing to rapidly growing patient pool, increase in public–private investments, and rise in number of strategic developments among the key players.

Purchase the Report: https://www.alliedmarketresearch.com/purchase-enquiry/1715

Our Market Research Solution Provides You Answer to Below Mentioned Question:

• Which are the driving factors responsible for the growth of market?
• Which are the roadblock factors of this market?
• What are the new opportunities, by which market will grow in coming years?
• What are the trends of this market?
• Which are main factors responsible for new product launch?
• How big is the global & regional market in terms of revenue, sales and production?
• How far will the market grow in forecast period in terms of revenue, sales and production?
• Which region is dominating the global market and what are the market shares of each region in the overall market in 2022?
• How will each segment grow over the forecast period and how much revenue will these segments account for in 2030?
• Which region has more opportunities?

By Region Outlook 

• North America
  (U.S., Canada, Mexico)
• Europe
  (Germany, France, UK, Italy, Spain, Rest of Europe)
• Asia-Pacific
  (Japan, China, India, Rest of Asia-Pacific)
• LAMEA
  (Brazil, Saudi Arabia, South Africa, Rest of LAMEA)

Contact Details:

David Correa
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
help@alliedmarketresearch.com

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.